H E Rugstad - JoVE Visualize

Showing results (41-50 of 82) with videos related to

Pageof 9

Sort By:

International Journal of Clinical Pharmacology and Therapeutics|April 28, 2000

Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP)G Lehne, L Mørkrid, M den Boer, et al.

American Heart Journal|January 1, 1991

Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experienceI Holme, P Fauchald, H E Rugstad, et al.

Acta Pharmacologica Et Toxicologica|March 1, 1982

The absorption and excretion of methyldopa ingested concomitantly with amino acids or food rich in proteinO Stenbaek, E Myhre, H E Rugstad, et al.

Therapeutic Drug Monitoring|February 1, 1994

Kinetics of mercaptopurine and thioguanine nucleotides in renal transplant recipients during azathioprine treatmentS Bergan, H E Rugstad, O Bentdal, et al.

Anticancer Research|March 1, 1991

Induction of in vitro resistance to 4'-epidoxorubicin and cis-dichlorodiammineplatinum in hepatoma cellsK S Hall, L Endresen, H S Huitfeldt, et al.

Therapeutic Drug Monitoring|January 8, 1998

Analysis of methylated 6-mercaptopurine metabolites in human red blood cells: comparison of two methodsT Giverhaug, S Bergan, T Loennechen, et al.

British Journal of Cancer|December 1, 1996

Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclinesG Lehne, P De Angelis, O P Clausen, et al.

British Journal of Anaesthesia|October 1, 1986

Interaction of cyclosporin and its solvent, Cremophor, with atracurium and vecuronium. Studies in the catL Gramstad, J A Gjerløw, E S Hysing, et al.

Science (New York, N.Y.)|October 30, 1970

Transfer of bilirubin uridine diphosphate-glucuronyltransferase to enzyme-deficient ratsH E Rugstad, S H Robinson, C Yannoni, et al.

Leukemia|June 22, 1999

Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agentsG Lehne, P De Angelis, M den Boer, et al.

Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:

Pageof 9

International Journal of Clinical Pharmacology and Therapeutics|April 28, 2000

Diverse effects of P-glycoprotein inhibitory agents on human leukemia cells expressing the multidrug resistance protein (MRP)G Lehne, L Mørkrid, M den Boer, et al.

American Heart Journal|January 1, 1991

Preliminary results of the Norwegian doxazosin postmarketing surveillance study: a twelve-week experienceI Holme, P Fauchald, H E Rugstad, et al.

Acta Pharmacologica Et Toxicologica|March 1, 1982

The absorption and excretion of methyldopa ingested concomitantly with amino acids or food rich in proteinO Stenbaek, E Myhre, H E Rugstad, et al.

Therapeutic Drug Monitoring|February 1, 1994

Kinetics of mercaptopurine and thioguanine nucleotides in renal transplant recipients during azathioprine treatmentS Bergan, H E Rugstad, O Bentdal, et al.

Anticancer Research|March 1, 1991

Induction of in vitro resistance to 4'-epidoxorubicin and cis-dichlorodiammineplatinum in hepatoma cellsK S Hall, L Endresen, H S Huitfeldt, et al.

Therapeutic Drug Monitoring|January 8, 1998

Analysis of methylated 6-mercaptopurine metabolites in human red blood cells: comparison of two methodsT Giverhaug, S Bergan, T Loennechen, et al.

British Journal of Cancer|December 1, 1996

Human hepatoma cells rich in P-glycoprotein are sensitive to aclarubicin and resistant to three other anthracyclinesG Lehne, P De Angelis, O P Clausen, et al.

British Journal of Anaesthesia|October 1, 1986

Interaction of cyclosporin and its solvent, Cremophor, with atracurium and vecuronium. Studies in the catL Gramstad, J A Gjerløw, E S Hysing, et al.

Science (New York, N.Y.)|October 30, 1970

Transfer of bilirubin uridine diphosphate-glucuronyltransferase to enzyme-deficient ratsH E Rugstad, S H Robinson, C Yannoni, et al.

Leukemia|June 22, 1999

Growth inhibition, cytokinesis failure and apoptosis of multidrug-resistant leukemia cells after treatment with P-glycoprotein inhibitory agentsG Lehne, P De Angelis, M den Boer, et al.

Pageof 9